Top Story

Late mortality, morbidity rates increase among survivors of adult Hodgkin's lymphoma

March 27, 2015

Survivors of adult Hodgkin’s lymphoma face high risks for late mortality from other causes, as well as late medical morbidity, according to study results.

Medical advances have greatly improved survival for patients with Hodgkin’s lymphoma. However, as survivorship increases, the effects of late treatment-related complications are becoming more apparent.

Jennifer R. Brown, MD, PhD In the Journals

Addition of ibrutinib to chemoimmunotherapy shows promise for CLL

March 26, 2015
The addition of ibrutinib to chemoimmunotherapy enhanced clinical activity in previously treated patients with chronic lymphocytic leukemia patients, according to study…
Jorge J. Castillo, MD In the Journals

Waldenström’s macroglobulinemia increases risk for secondary malignancies

March 25, 2015
Patients with Waldenström’s macroglobulinemia demonstrated an increased risk for secondary malignancies compared with the general population, according to…
In the Journals

Poor outcomes likely for ibrutinib-resistant patients with mantle cell lymphoma

March 24, 2015
Patients with mantle cell lymphoma who experience progression after ibrutinib treatment likely will not respond to salvage chemotherapy, according to results of a…
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
Genome editing demonstrated wide application for blood disorders

Genome editing demonstrated wide application for blood disorders

January 4, 2015
SAN FRANCISCO — Ralph Green, MD, PhD, FRCPath, medical director of the UC Davis Health System Medical…
More »
CME CNE
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
In the Journals

Late mortality, morbidity rates increase among survivors of adult Hodgkin's lymphoma

March 27, 2015
Survivors of adult Hodgkin’s lymphoma face high risks for late mortality from other causes, as well as late medical morbidity, according to…
Jennifer R. Brown, MD, PhD In the Journals

Addition of ibrutinib to chemoimmunotherapy shows promise for CLL

March 26, 2015
The addition of ibrutinib to chemoimmunotherapy enhanced clinical activity in previously treated patients with chronic lymphocytic leukemia patients…
Jorge J. Castillo, MD In the Journals

Waldenström’s macroglobulinemia increases risk for secondary malignancies

March 25, 2015
Patients with Waldenström’s macroglobulinemia demonstrated an increased risk for secondary malignancies compared with the general…
In the Journals

Poor outcomes likely for ibrutinib-resistant patients with mantle cell lymphoma

March 24, 2015
Patients with mantle cell lymphoma who experience progression after ibrutinib treatment likely will not respond to salvage chemotherapy, according to…
In the Journals

HSCT access limited by country, cost

March 23, 2015
Although the number of hematopoietic stem cell transplants performed worldwide reached 1 million in 2012, the procedure is primarily utilized by…
In the Journals

Prior MGUS diagnosis increases multiple myeloma survival

March 18, 2015
Patients with multiple myeloma who were previously diagnosed with monoclonal gammopathy of undetermined significance demonstrated improved OS…
In the Journals

Radiation dose for Hodgkin's lymphoma may increase valvular heart disease risk

March 17, 2015
Patients who receive radiation to the heart valves during treatment for Hodgkin’s lymphoma may be at increased risk for clinically significant…
Sagar Lonial, MD In the Journals

Frailty score helps predict risk for mortality, toxicity in elderly myeloma

March 13, 2015
A frailty score based on a geriatric assessment of age, comorbidities, and cognitive and physical status accurately predicted the risks for mortality…
In the Journals

Sexual transmission of HTLV-1 documented in French male

March 13, 2015
Researchers in France have documented sexual transmission of human T-cell lymphotropic virus, which is normally passed to young children during…
Jennifer A. Woyach, MD In the Journals

Ibrutinib discontinuation linked to poor prognosis in CLL

March 12, 2015
Discontinuation of ibrutinib therapy for chronic lymphocytic leukemia due to progressive disease was associated with a poor prognosis, especially…
More Headlines »
morganatic-roan